Other specified type of carcinoma in situ of left breast refers to a non-invasive breast cancer that is localized and has not spread beyond the ducts or lobules. This condition is clinically significant as it can progress to invasive cancer if left untreated. The ICD-10 Code D05.82 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage patient care.
What is ICD-10 Code D05.82 for Other specified type of carcinoma in situ of left breast?
ICD-10 Code D05.82 represents a diagnosis of Other specified type of carcinoma in situ of left breast, indicating a specific form of non-invasive breast cancer. This code is used when the carcinoma is identified but does not fit into more specific categories. It is essential for clinical documentation and billing to ensure appropriate treatment and follow-up care.
ICD-10 Code D05.82 – Clinical Definition and Explanation of Other specified type of carcinoma in situ of left breast
Other specified type of carcinoma in situ of left breast is characterized by abnormal cell growth within the breast tissue that has not invaded surrounding tissues. This condition requires medical attention due to its potential to develop into invasive breast cancer if not monitored and treated appropriately.
Key Clinical Features:
- Presence of atypical cells in breast tissue without invasion.
- May be asymptomatic or present with localized symptoms.
- Requires regular monitoring and potential surgical intervention.
- Higher risk of progression to invasive carcinoma if untreated.
ICD-10 Code D05.82 for Other specified type of carcinoma in situ of left breast – SOAP Notes & Clinical Use
In SOAP notes, ICD-10 Code D05.82 is utilized to document the diagnosis of Other specified type of carcinoma in situ of left breast. It plays a crucial role in capturing patient symptoms, assessment findings, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
What Does ICD-10 Code D05.82 for Other specified type of carcinoma in situ of left breast Mean in SOAP Notes?
ICD-10 Code D05.82 connects subjective patient reports and objective clinical findings to a formal diagnosis of Other specified type of carcinoma in situ of left breast. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code D05.82 – Other specified type of carcinoma in situ of left breast
The management of Other specified type of carcinoma in situ of left breast may require hospitalization for surgical intervention or close monitoring. Treatment approaches focus on preventing progression to invasive cancer.
Antibiotic Therapy:
Supportive Care:
- Regular follow-up appointments for monitoring.
- Patient education on signs of progression.
- Psychosocial support for coping with diagnosis.
Infection Control:
How to Document Symptoms of Other specified type of carcinoma in situ of left breast (ICD-10 D05.82) in SOAP Notes
Subjective:
- Patient reports a lump in the left breast.
- No pain or discomfort noted.
- Family history of breast cancer.
- Concerns about potential progression.
Objective:
- Breast examination reveals a palpable mass in the left breast.
- Mammogram shows suspicious calcifications.
- Biopsy confirms carcinoma in situ.
- No lymphadenopathy detected.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Other specified type of carcinoma in situ of left breast (ICD-10 Code D05.82)
Assessment:
- Diagnosis: Other specified type of carcinoma in situ of left breast, moderate severity.
- ICD-10 Subcode: D05.82.
- Contributing factors: Family history of breast cancer.
Plan:
- Refer for surgical consultation for potential lumpectomy.
- Schedule follow-up imaging in 6 months.
- Provide education on self-breast examination techniques.
- Discuss genetic counseling options.
Treatment & Plan Section for ICD-10 Code D05.82 – Other specified type of carcinoma in situ of left breast
- Surgical intervention may include lumpectomy or mastectomy.
- Consideration of radiation therapy post-surgery.
- Regular follow-up with imaging to monitor for changes.
- Patient education on lifestyle modifications to reduce risk.
Using ICD-10 Code D05.82 for Other specified type of carcinoma in situ of left breast in Billing & SOAP Note Compliance
- Ensure accurate documentation of symptoms and findings in SOAP notes.
- Use D05.82 in settings where carcinoma in situ is diagnosed.
- Align treatment plans with clinical guidelines for justified billing.
- Document any relevant comorbidities or complications.
Related ICD-10 Codes Often Used with Other specified type of carcinoma in situ of left breast
- D05.81 – Carcinoma in situ of right breast
- D05.00 – Carcinoma in situ of unspecified breast
- C50.911 – Malignant neoplasm of left breast, unspecified
ICD-10 Code D05.82 in Medical Billing and Insurance for Other specified type of carcinoma in situ of left breast
ICD-10 Code D05.82 is crucial for billing purposes in hospital, ER, or oncology settings, ensuring accurate reimbursement for services rendered.
Billing Notes:
- Document all relevant clinical findings to support the diagnosis.
- Use D05.82 in conjunction with treatment codes for comprehensive billing.
- Ensure compliance with payer guidelines for documentation.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 19301 | Mastectomy, partial (lumpectomy) |
| 19303 | Mastectomy, total |
| 77067 | Breast imaging, diagnostic mammography |
| 88305 | Pathology examination of breast tissue |
Frequently Asked Questions
Common Questions About Using ICD-10 Code D05.82 for Other specified type of carcinoma in situ of left breast
What are the treatment options for carcinoma in situ of the left breast?
Treatment options typically include surgical intervention such as lumpectomy or mastectomy, followed by radiation therapy. Regular monitoring and follow-up care are essential to prevent progression to invasive cancer.
How is the diagnosis of carcinoma in situ made?
Diagnosis is made through imaging studies such as mammograms and confirmed by biopsy, which reveals atypical cells in the breast tissue without invasion.
Is carcinoma in situ considered cancer?
Yes, carcinoma in situ is classified as a non-invasive form of breast cancer. While it does not spread beyond the ducts or lobules, it requires treatment to prevent progression to invasive cancer.
What is the prognosis for patients with carcinoma in situ?
The prognosis for patients with carcinoma in situ is generally favorable, especially with early detection and appropriate treatment. Regular follow-up is crucial for monitoring.
